| Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma (NCT04861480) | Chongqing Precision Biotech Co., Ltd | 2021-06-16 |
| Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients (NCT04940546) | Sun Yat-sen University | 2021-06-16 |
| Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (NCT04789655) | Celgene | 2021-06-16 |
| Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies (NCT04649112) | Precision BioSciences, Inc. | 2021-06-16 |
| PanDox: Targeted Doxorubicin in Pancreatic Tumours (NCT04852367) | University of Oxford | 2021-06-16 |
| The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication (NCT04800692) | Louis Messina | 2021-06-15 |
| Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine (NCT04930003) | Research Institute for Biological Safety Problems | 2021-06-15 |
| Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer (NCT04327986) | National Cancer Institute (NCI) | 2021-06-15 |
| GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies (NCT04937153) | Genmab | 2021-06-15 |
| A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment (NCT04859439) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-06-15 |
| RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration (NCT04895293) | Maturi, Raj K., M.D., P.C. | 2021-06-15 |
| Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors (NCT04892017) | Deciphera Pharmaceuticals, LLC | 2021-06-15 |
| Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function. (NCT04909853) | Pfizer | 2021-06-15 |
| A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma (NCT04905602) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-06-15 |
| Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain (NCT05037539) | Department of Medical Services Ministry of Public Health of Thailand | 2021-06-15 |
| Phase I Study of CPI-300 in Patients With Advanced Tumors (NCT04808453) | Coordination Pharmaceuticals, Inc. | 2021-06-15 |
| A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption (NCT04926051) | Bristol-Myers Squibb | 2021-06-15 |
| CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI) (NCT04060407) | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2021-06-15 |
| Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma (NCT04662112) | Asan Medical Center | 2021-06-15 |
| Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers. (NCT05835934) | Haisco Pharmaceutical Group Co., Ltd. | 2021-06-15 |
| Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women (NCT04940026) | Sanofi | 2021-06-15 |
| FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies (NCT04891757) | Foghorn Therapeutics Inc. | 2021-06-14 |
| A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults (NCT04886154) | GlaxoSmithKline | 2021-06-14 |
| Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)? (NCT05001750) | Montefiore Medical Center | 2021-06-14 |
| A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody (NCT04866485) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-06-14 |
| A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer (NCT04729114) | Astellas Pharma Global Development, Inc. | 2021-06-14 |
| A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018) (NCT04846920) | Merck Sharp & Dohme LLC | 2021-06-14 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects (NCT04838639) | Otsuka Pharmaceutical Factory, Inc. | 2021-06-14 |
| A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction (NCT04855201) | Astellas Pharma Global Development, Inc. | 2021-06-14 |
| Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients (NCT04804514) | HysensBio Co., Ltd | 2021-06-14 |
| A Trial of SHR-1703 in Healthy Subjects (NCT04855591) | Atridia Pty Ltd. | 2021-06-14 |
| A Study of LY3819469 in Healthy Participants (NCT04914546) | Eli Lilly and Company | 2021-06-14 |
| A Food Effect Study of ZN-d5 in Healthy Female Volunteers (NCT04854174) | K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | 2021-06-13 |
| PhI to Solid Tumors and PhII to Locally Advanced or mTNBC (NCT05390710) | Laekna Limited | 2021-06-12 |
| Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma (NCT04840615) | National Cancer Institute (NCI) | 2021-06-11 |
| Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China (NCT04894825) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2021-06-11 |
| To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines. (NCT04944953) | Hugel | 2021-06-11 |
| Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer (NCT04907968) | Mersana Therapeutics | 2021-06-11 |
| Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia (NCT04848974) | M.D. Anderson Cancer Center | 2021-06-11 |
| Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT04958434) | Suzhou Transcenta Therapeutics Co., Ltd. | 2021-06-11 |
| Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects (NCT05293171) | BioLineRx, Ltd. | 2021-06-11 |
| Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects (NCT04914520) | Daiichi Sankyo Co., Ltd. | 2021-06-11 |
| Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma (NCT04990479) | Nouscom SRL | 2021-06-11 |
| Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca (NCT04921904) | Baylor Research Institute | 2021-06-11 |
| HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer (NCT04676477) | Daiichi Sankyo | 2021-06-11 |
| A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects (NCT04926701) | Enterprise Therapeutics Ltd | 2021-06-11 |
| Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies (NCT04865419) | AstraZeneca | 2021-06-11 |
| A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer (NCT04702737) | Amgen | 2021-06-10 |
| Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment (NCT04739527) | University Medical Center Groningen | 2021-06-10 |
| A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008 (NCT04946903) | Hanmi Pharmaceutical Company Limited | 2021-06-10 |
| IFx-Hu2.0 for the Treatment of Patients With Skin Cancer (NCT04925713) | TuHURA Biosciences, Inc. | 2021-06-10 |
| Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC (NCT05157542) | Juan LI, MD | 2021-06-10 |
| Phase 1 Study of Epetraborole Tablets (NCT04892641) | AN2 Therapeutics, Inc | 2021-06-10 |
| A Study of LY3532226 in Healthy Participants (NCT04923269) | Eli Lilly and Company | 2021-06-10 |
| Study of EMB-001 as a Potential Smoking Cessation Treatment (NCT04933916) | Embera NeuroTherapeutics, Inc. | 2021-06-10 |
| AST-021p Study in Advanced Solid Tumors (NCT04864418) | Aston Sci. Inc. | 2021-06-09 |
| A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment (NCT04859426) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-06-09 |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets (NCT04853498) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-06-09 |
| A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment (NCT04928677) | Memorial Sloan Kettering Cancer Center | 2021-06-09 |
| Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL (NCT04855253) | Masonic Cancer Center, University of Minnesota | 2021-06-09 |
| Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NCT04913337) | NGM Biopharmaceuticals, Inc | 2021-06-09 |
| A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation (NCT04411303) | University of Southern California | 2021-06-09 |
| Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment (NCT04706598) | Fudan University | 2021-06-09 |
| Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma (NCT04901702) | St. Jude Children's Research Hospital | 2021-06-09 |
| A Study of AK3280 in Chinese Healthy Volunteers (NCT04926116) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2021-06-09 |
| To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (NCT04843319) | Veru Inc. | 2021-06-09 |
| Study of Midazolam in Healthy Adults (NCT04679623) | Rafa Laboratories | 2021-06-09 |
| VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers (NCT04877379) | Basilea Pharmaceutica | 2021-06-08 |
| Dose Escalation Trial of BNT152+153 in Patients With Cancer (NCT04710043) | BioNTech SE | 2021-06-08 |
| A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) (NCT04834778) | HiberCell, Inc. | 2021-06-08 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers (NCT04908462) | AceLink Therapeutics, Inc. | 2021-06-08 |
| Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function (NCT04865393) | Spero Therapeutics | 2021-06-08 |
| Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor (NCT04465643) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-06-08 |
| Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer (NCT04511039) | Roswell Park Cancer Institute | 2021-06-08 |
| Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. (NCT04839991) | Crescendo Biologics Ltd. | 2021-06-08 |
| A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide (NCT04903509) | Boehringer Ingelheim | 2021-06-08 |
| Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis (NCT04943653) | Seoul St. Mary's Hospital | 2021-06-08 |
| Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy Adults (NCT05976386) | Sanofi | 2021-06-08 |
| Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer (NCT04481113) | OHSU Knight Cancer Institute | 2021-06-07 |
| Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants (NCT04933682) | Alexion Pharmaceuticals, Inc. | 2021-06-07 |
| Comparative Bioavailability of XS004 (Dasatinib) Formulation G and SPRYCEL® (Dasatinib) in Healthy, Adult Subjects Under Fasting Conditions (NCT05439408) | Xspray Pharma AB | 2021-06-07 |
| KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma (NCT04601610) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2021-06-07 |
| A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects (NCT04873323) | Taisho Pharmaceutical Co., Ltd. | 2021-06-07 |
| A Study to Investigate the Drug-drug Interactions (DDIs) Between SKLB1028 and Midazolam in Healthy Subjects (NCT05070195) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-06-07 |
| AMI-DC in Patients With Anterior Wall Myocardial Infarction (NCT05554484) | The Catholic University of Korea | 2021-06-07 |
| Study of XB002 in Subjects With Solid Tumors (JEWEL-101) (NCT04925284) | Exelixis | 2021-06-07 |
| Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury (NCT05337774) | Lantheus Biosciences Ltd. | 2021-06-07 |
| A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy Subjects (NCT05069870) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-06-07 |
| A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants (NCT04388501) | Janssen Pharmaceutica N.V., Belgium | 2021-06-07 |
| A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer (NCT04872166) | Edgewood Oncology Inc. | 2021-06-07 |
| Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970 (NCT04907149) | Lakefront Biotherapeutics NV | 2021-06-07 |
| A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC (NCT04672369) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-06-06 |
| Application of Probiotic PS128 in Children With ASD (NCT04942522) | Yan Hao | 2021-06-06 |
| Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (NCT05000450) | Allogene Therapeutics | 2021-06-06 |
| Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases (NCT04887298) | Moleculin Biotech, Inc. | 2021-06-05 |
| A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer (NCT04881981) | Baptist Health, Louisville | 2021-06-05 |
| A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC (NCT04331743) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-06-05 |
| Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions (NCT04921566) | Pharmtechnology LLC | 2021-06-05 |
| A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT04808570) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-06-05 |
| Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions (NCT04906785) | Chong Kun Dang Pharmaceutical | 2021-06-04 |